Skip to main content
Midas Edge

DarioHealth Corp

For the period ended Dec 31, 2024. Filed Mar 10, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 10, 2025

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Statements of Changes in Stockholders’ Equity

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of January 1, 202325,724,470​$3​3,567​$*) -​$365,846​$(285,850)​$79,999
​​​​​​​​​​​​​​​​​​​​
Exercise of options4,800​​*) -​—​​—​​—​​—​​*) -
Exercise of warrants86,983​​*) -​—​​—​​—​​—​​—
Extinguishment of preferred stock in connection with preferred stock modification—​​—​—​​—​​984​​(984)​​—
Deemed dividend related to issuance of preferred stock—​​—​—​​—​​3,100​​(3,100)​​—
Conversion of preferred stock to common stock3,582​​*) -​(10)​​—​​—​​—​​*) -
Issuance of warrants to service providers​—​​—​—​​—​​3,516​​—​​3,516
Stock-based compensation​887,334​​*) -​—​​—​​16,185​​—​​16,185
Issuance of Common Stock, net of issuance cost​408,043​​*) -​15,402​​—​​16,482​​—​​16,482
Common stock related to earnout consideration​76,637​​*) -​—​​—​​—​​​​​*) -
Issuance of warrants related to loan agreement, net of issuance cost—​​—​—​​—​​1,389​​—​​1,389
Net loss—​​—​—​​—​​—​​(59,427)​​(59,427)
​​​​​​​​​​​​​​​​​​​​
Balance as of December 31, 202327,191,849​$3​18,959​$*) -​$407,502​$(349,361)​$58,144
​​​​​​​​​​​​​​​​​​​​
Exercise of options​10,714​​*) -​—​​—​​—​​—​​*) -
Exercise of pre-funded warrant to common stock3,187,101​​*) -​—​​—​​2,225​​—​​2,225
Extinguishment of preferred stock in connection with preferred stock modification​—​​—​—​​​​​(12,194)​​12,194​​—
Deemed dividend related to issuance of preferred stock—​​—​—​​—​​10,429​​(10,429)​​—
Conversion of preferred stock to common stock4,807,489​​*) -​(10,601)​​*) -​​—​​—​​*) -
Issuance of warrants to service providers​—​​—​—​​—​​2,704​​—​​2,704
Stock-based compensation​3,191,278​​*) -​—​​—​​13,092​​—​​13,092
Issuance of preferred stock, net of issuance cost​—​​1​41,227​​*) -​​38,530​​—​​38,531
Modification of warrants—​​—​—​​—​​70​​—​​70
Net loss—​​—​—​​—​​—​​(42,747)​​(42,747)
​​​​​​​​​​​​​​​​​​​​
Balance as of December 31, 202438,388,431​$4​49,585​$*) -​$462,358​$(390,343)​$72,019

*) Represents an amount lower than $1.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.